Sodium Bicarbonate 8.4% w/v, 25mL Injection

Sodium Bicarbonate 8.4% w/v Injection, 25mL is an intravenous alkalinizing solution used in monitored medical settings for metabolic acidosis or selected poisoning/urine-alkalinization situations for sodium bicarbonate treatment. It increases bicarbonate and raises blood or urine pH, helping buffer excess acid in specific clinical contexts such as severe renal disease, uncontrolled diabetes with acidosis, shock-related acidosis, severe dehydration, cardiac arrest protocols, or toxin elimination plans. Over-correction can cause metabolic alkalosis, high sodium, fluid overload, low potassium, low calcium symptoms, tissue injury from extravasation, and shifts in oxygen delivery.
Sodium Bicarbonate 8.4% w/v Injection, 25mL is given by trained healthcare professionals by IV route. Dose, dilution, infusion rate, and monitoring depend on acid-base status, electrolytes, kidney function, and clinical indication.
Sodium bicarbonate supplies bicarbonate ions that buffer hydrogen ions, increasing systemic or urinary pH when alkalinization is clinically needed.
Possible effects include vein irritation, fluid overload, swelling, high sodium, low potassium, low calcium symptoms, and alkalosis. Serious concerns include arrhythmia, tetany, seizures, tissue injury from extravasation, worsening CO2 burden, and severe fluid overload.
Review blood gas results, sodium/potassium/calcium, kidney function, heart failure, edema, hypertension, respiratory status, chloride depletion, vomiting, diuretic use, pregnancy, eclampsia risk, and infusion compatibility.
Metabolic acidosis correction or selected toxin/urine-alkalinization protocols when IV sodium bicarbonate is prescribed.
Provides rapid alkalinization in supervised settings where acid-base correction is clinically indicated and monitored.
Sodium Bicarbonate 8.4% w/v Injection, 25mL is used in monitored settings for metabolic acidosis or selected poisoning/alkalinization protocols.
No. This is an injectable product for clinical use, not an over-the-counter acidity remedy.
IV bicarbonate can affect sodium, potassium, calcium, fluid balance, and blood pH.
Over-treatment can cause metabolic alkalosis, high sodium, fluid overload, twitching, tetany, or heart rhythm problems.
People with heart failure, kidney disease, edema, high blood pressure, respiratory failure, chloride depletion, or sodium restriction need careful review.
Sodium bicarbonate, IV alkalinizing agent, Metabolic acidosis treatment, Blood pH correction, Hypernatremia alkalosis warning, Electrolyte monitoring, AR: Sodium Bicarbonate 8.4% w/v, حقن, FR: Sodium Bicarbonate 8.4% w/v, PT: Sodium Bicarbonate 8.4% w/v, injeção, ES: Sodium Bicarbonate 8.4% w/v, inyección, RU: Sodium Bicarbonate 8.4% w/v, инъекция, ID: Sodium Bicarbonate 8.4% w/v, injeksi, VI: Sodium Bicarbonate 8.4% w/v, thuốc tiêm, MS: Sodium Bicarbonate 8.4% w/v, suntikan, TL: Sodium Bicarbonate 8.4% w/v, iniksyon, ZH-SG: Sodium Bicarbonate 8.4% w/v, 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Sodium Bicarbonate 8.4% w/v, 25mL Injection under Anaesthesia Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Sodium Bicarbonate 8.4% w/v, 25mL Injection